Adequacy of anticoagulant prevention in patients with atrial fibrillation;Adecuación de la profilaxis anticoagulante en pacientes con fibrilación auricular

Revista de Neurologia

Volumn 41, Issue 7, 2005, Pages 399-403

  García García, Jorge ^a   Calleja Puerta, S ^a   De La Vega Cerezales, V ^a   Benavente Fernandez L ^a   Rodriguez Rodriguez S ^a   Hernandez Lahoz C ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Atrial fibrillation; Cardioembolic stroke; Oral anticoagulants; Prognosis; Prophylaxis; Stroke

Indexed keywords

ANTICOAGULANT AGENT; DIGOXIN;

AGE; ANAMNESIS; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG INDICATION; FEMALE; FUNCTIONAL ASSESSMENT; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRESCRIPTION; RANKIN SCALE; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; AGED; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 33644814592     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4107.2005231     Document Type: Article

References (26)

1. Mohr JP, Torbicki A, Perlmutter RA, Caplan LR, Melski JW. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978; 28: 754-5.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a mayor contribution to Stroke in the elderly. The Framingham study. Stroke 1991; 22: 983-8.
3. Averinos JF, Brown RD, Foley DA, Nkomo V, Petty G, Scout C, et al. Cerebral events after diagnosis of mitral valve prolapse. A community-based study of incident and predictive factors. Stroke 2003; 34: 1339-45.
4. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a metaanalysis. Ann Int Med 1999; 131: 494-501.
5. Anderson M, Kira M. Anticoagulation in atrial fibrillation. Med Health R I 2004; 87: 98-100.
6. Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3,169 patients with acute ischemic stroke in atrial fibrillation in the International Stroke Trial. Stroke 2001; 32: 2333-7. BIBLIOGRAFÍA
7. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of tromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1989; 1: 175-9.
8. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cains JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation. (CAFA) Study. Stroke 1991; 22: 983-8.
9. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-11.
10. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 1991; 84: 527-39.
11. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687-91.
12. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992; 327: 1406-12.
13. European Atrial Fibrillation Trial (EAFT) Study group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 1993; 342: 1255-62.
14. Stroke Prevention in Atrial Fibrillation Investigators. Preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med 1990; 332: 863-8.
15. Deplanque D, Leys D, Parnetti L, Schimdt R, Ferro J, De Reuck J, et al. The SAFE II Investigators. Stroke prevention and atrial fibrillation: results leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol 2003; 57: 798-806.
16. García-Escrivá A, López-Hernández N, Hernández-Lorido R, Oliver-Navarrete C, Bustos S, Carneado-Ruiz J, et al. Modificación del perfil clínico de los ictus en enfermos con fibrilación auricular. Efecto del tratamiento antitrombótico. Rev Neurol 2004; 38: 401-5.
17. Deplanque D, Corea F, Arquizan C, Parnetti L, Mas JL, SAFE I Study investigators, et al. Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? Heart 1999; 82: 563-9.
18. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
19. Chong-Ji Y, Mohr-Jay P. Anticoagulation and platelet antiagregation therapy in stroke. Curr Opin Neurol 2005; 18: 53-7.
20. Smith NL, Psaty BM, Furberg CD, White R, Lima JA, Newman AB, et al. Temporal trends in the use of anticoagulation among older adults with atrial fibrillation. Arch Intern Med 1999; 159: 1574-8.
21. Hart RG, Halperin JL. Atrial fibrillation and stroke; concepts and controversies. Stroke 2001; 32: 803-8.
22. Laupacis A, Alberg G, Dalen J, Dunn M, Feinberg W, Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest 1995; 108 (Suppl): 352-9.
23. Aloy-Duch A, Cuenca-Luque R, Rollán-Serrano E, Casonota-Sandoval JM. Utilización de fármacos antitrombóticos en pacientes con fibrilación auricular crónica en un área sanitaria comarcal. Med Clin (Barc) 1999; 112: 454-6.
24. Bertomeu-Martínez V, Morrilas-Blasco PJ, González-Juanatey JR, Alegría-Ezquerra E, García-Acuña JM, González-Maqueda I, et al. Empleo de fármacos antitrombó ticos en pacientes hipertensos con fibrilación auricular crónica. Med Clin (Barc) 2002; 118: 327-31.
25. Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, McBride R, et al. Lessons from the stroke prevention in atrial fibrillation trials. Ann Intern Med 2003; 138: 831-8.
26. Maeda K, Shimbo T, Fukui T. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan. J Med Screen 2004; 11: 97-102.